What does CGAT mean in HOSPITALS

The Center for Genomic Applications and Therapeutics (CGAT) is an innovative institute that recognizes the need for genetic research to improve the efficacy of therapeutic treatments. CGAT's mission is to help develop new therapies and applications through the study of genomics and innovation in gene therapy, pharmacogenetics, bioinformatics, and more.

By studying the genome — the entire set of genetic material present in a cell — CGAT can better understand how changes in genes can alter a person's risk of developing certain diseases or health conditions. This information can then be used to develop targeted treatments that reduce risks or provide improved responses to drugs and other therapies.

Through its research, CGAT has developed novel gene therapy approaches such as CRISPR/Cas9-assisted gene editing, which has been used to create personalized medicine treatments targeting specific disease mutations with greater precision than before. Other technologies such as gene-activated immune-modulation therapy (GAMT) have also been developed at CGAT for providing personalized immunotherapies with increased efficacy.

By focusing on advancing innovations in genomic technology and therapeutics, CGAT helps ensure that healthcare professionals are able to utilize genomic knowledge for diagnosis and treatment decisions worldwide. In this way, global health improves through access to efficient medical care with reduced cost implications. Additionally, continued advancements in genomics help open up new opportunities for precision medicine treatments tailored toward individual patients.

By collaborating with international institutions such as universities, hospitals, industry partners, government agencies etc., CGAT effectively leverages knowledge within these communities while creating potential synergy effects between them. Such collaborations facilitate joint projects on a variety of topics ranging from biomarker discovery to clinical trial implementation all aimed at improving patient outcomes through genomics led advances.

Even during non-pandemic times when physical meetings were possible held limited by geographic distances or any other limitations due to logistics it was still difficult for stakeholders across two different locations/countries/continents to collaborate efficiently because availability was still dependent upon their respective location's time zones or real life commitments virtual meetings provide stakeholders a platform where they all could be available at once anytime regardless of their geographical distance making collaboration more efficient.

Data sharing enables more systemic analyses; fostering advances in disease understanding which ultimately leads to novel therapies discoveries. It also helps promote transparency around results from various projects enabling larger communities learn from each others' work which saves time, effort & money reducing redundant efforts towards same scientific projects